On a disclosed annual basis, sales fell from KRW 60.5 billion in 2022 to KRW 51.5 billion in 2023, a 15.0% decline, then rose to KRW 104.9 billion in 2024, up 103.9%, and to KRW 142 billion in 2025, up 35.3%. 2023 was the low point, and sales grew for two consecutive years from 2024 through 2025, with 2025 the largest year in the 2022 to 2025 period.
The operating margin went from 3.7% in 2022 to -5.8% in 2023, then 0.5% in 2024 and -0.4% in 2025. Operating profit turned positive in 2024 at KRW 487 million, but profit attributable to controlling shareholders was KRW 13.5 billion, far larger than operating profit.
That gap comes from non-operating items, and the line items should be checked in the notes to the annual report's income statement. In 2025 the company returned to an operating loss of KRW 610 million and a net loss attributable to controlling shareholders of KRW 8.6 billion.
On a quarterly basis, 2025 Q3 sales of KRW 35 billion with operating profit of KRW 323 million gave way to KRW 37.3 billion in sales and an operating loss of KRW 1.04 billion in Q4.
Sales dropped to KRW 16.2 billion in 2026 Q1, then rose to KRW 20.2 billion in Q2 and KRW 25.7 billion in Q3, two straight quarters of growth. Operating losses widened over the same stretch, reaching KRW 764 million in Q1, KRW 5.28 billion in Q2 and KRW 11.9 billion in Q3.
Per the company's own announcement, precursor sales in Q3 reached KRW 17.8 billion, which exceeded the first-half total of KRW 17.3 billion in a single quarter, but weak demand and fixed costs kept the company in the red.
The net loss attributable to controlling shareholders for the four quarters from 2025 Q4 to 2026 Q3 totals KRW 28.6 billion. Operating cash flow was negative at KRW -21.9 billion in 2024 and KRW -11.1 billion in 2025, and the debt ratio rose to 117.5% at the end of 2025 from 75.4% in 2022.